Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

This study has been completed.

Study NCT00154388 Information provided by Novartis

First Received: September 9, 2005 Last Updated: September 21, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given